FDA WARNING_LETTER - Tiger Coco
On December 14, 2016, the FDA's Center for Tobacco Products issued a Warning Letter to the operator of tigercoco.com after reviewing their website and determining that e-liquid products were offered for sale in the U.S. The eCigaretteWeb Chocolate e-liquid was identified as a tobacco product under section 201(rr) of the FD&C Act.
The primary violation cited was the sale of eCigaretteWeb Chocolate e-liquid to a person younger than 18 years of age, which constitutes misbranding under section 903(a)(7)(B) of the FD&C Act. This violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquids, to minors.
The FDA requires immediate correction of this and similar violations to ensure compliance with the FD&C Act and its implementing regulations. Failure to comply may result in further actions, including civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Adulterated and misbranded tobacco products imported into the U.S. are subject to detention.
A written response detailing corrective actions, including dates of discontinued violative sales and a plan for maintaining compliance, must be submitted within 15 working days of receipt of the letter. The reference number for the
- Company
- Tiger Coco
- Product type
- Tobacco
ID · c2c1293c-12ef-4de8-a309-c8871a4634ef
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.